Stefan A. Stanko is the Head of Sales for the U.S. Cardiology Business Unit at BTG Pharmaceuticals. Prior to their current role, Stefan A. held positions at Kyowa Kirin, Inc., Phyxius Therapeutics, Inc., Portola Pharmaceuticals, CSL Behring, Phyxius Pharma, Inc., Phyxius Pharma, LLC, The Medicines Company, PDL BioPharma, and Sanofi. Stefan's educational background includes a Bachelor of Business Administration with a double major in Marketing & Management from Baylor University and a Master Class Direct degree from UCSF Innovation Ventures.